ropinirole has been researched along with Heart Valve Diseases in 5 studies
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Excerpt | Relevance | Reference |
---|---|---|
"To determine if cardiac valve regurgitation occurs more commonly in patients with Parkinson disease (PD) treated with pergolide than in those treated with nonergot agonists at a comparable dose." | 7.74 | Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease. ( Dewey, RB; O'Suilleabhain, PE; Reimold, SC, 2007) |
"To determine if cardiac valve regurgitation occurs more commonly in patients with Parkinson disease (PD) treated with pergolide than in those treated with nonergot agonists at a comparable dose." | 3.74 | Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease. ( Dewey, RB; O'Suilleabhain, PE; Reimold, SC, 2007) |
"This review describes the pharmacologic and pharmacokinetic properties of selected DAs and relates these characteristics to clinical outcomes, with an emphasis on adverse events." | 2.43 | A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. ( Burger, E; Härtter, S; Kvernmo, T, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bares, M | 1 |
Rektorová, I | 1 |
Krajcovicová, L | 1 |
Rektor, I | 1 |
Andersohn, F | 1 |
Garbe, E | 1 |
Kvernmo, T | 1 |
Härtter, S | 1 |
Burger, E | 1 |
Junghanns, S | 1 |
Fuhrmann, JT | 1 |
Simonis, G | 1 |
Oelwein, C | 1 |
Koch, R | 1 |
Strasser, RH | 1 |
Reichmann, H | 1 |
Storch, A | 1 |
Dewey, RB | 1 |
Reimold, SC | 1 |
O'Suilleabhain, PE | 1 |
1 review available for ropinirole and Heart Valve Diseases
Article | Year |
---|---|
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; | 2006 |
1 trial available for ropinirole and Heart Valve Diseases
Article | Year |
---|---|
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Fe | 2007 |
3 other studies available for ropinirole and Heart Valve Diseases
Article | Year |
---|---|
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Disea | 2008 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual | 2009 |
Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Echocard | 2007 |